You Want Me to Go Bald on Purpose?

Shave to Save: Giving Hope a Head Start is one of the most creative fundraisers I’ve heard of. Besides the cleverness of the tag line, I appreciate the courage of the participants. Shave to Save is an event where men and women volunteer to shave their heads in honor or memory of someone that has been touched by cancer.

Here’s how it works – local American Cancer Society organization or other groups organize an event and people willing to have their head shaved register. Then they ask family and friends to donate to the fund- if they reach their goal, their locks are shorn. And even if they don’t meet their goal, they shave anyway. Otherwise, there would be lots of folks setting a million bucks as their goal.

The other nice thing about the events is that it is a way for schools, businesses and other community to groups to show support to a member of their own community that may be affected by cancer, particularly if they are undergoing chemo and lost hair.

Wanna catch a promo video? Check it out here:
http://www.youtube.com/watch?v=YALNeHU5l9U
If you might be interested in sponsoring a local event, contact a cancer organization that you would like to support and ask for help in planning a special outreach event.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap